Blog >

Best Pharma Stocks in India To Buy in 2025

Best Pharma Stocks in India To Buy in 2025

Best pharma stocks in India To Buy

India is the home for largest pharmaceutical companies because of their mass production of generic medications. India is the largest global producer of genric drugs and it produces 60% of global vaccine. Investing in pharmaceutical stocks has long been a prudent choice for investors seeking stability and growth potential in their portfolios. In this blog, we will explore the best pharma sector stocks in India.

 

Budget allocation for Healthcare Industry in Union Budget 2024-25

  • In Union budget 2024-25, The Finance minister Nirmala Sitharaman increase the health budget by 12.9% Rs 90,659 Cr. compare to 2023-24.
  • The department of Heath Research allocated Rs. 3,002 Cr, which is 4% rise on its estimated expenditure in 2023-24.

 

 
2022-23
2023-24 (RE) 2024-25 (BE) % Change from 2024-25
Health and Family Welfare 73308 77625 87657 0.13
Health Research 2423 2893 3002 0.04
Total 75731 80518 90659 0.13
  • National Health Mission account Rs.36,000 crore which is 40% of Union budget 2024-25. This budget is further divided between the states to meet the target.
  • Pradhan Mantri Jan Aarogya Yojana received Rs.7,300 Cr, this allocation is higher than the previous budget.
  • The India council of medial research increase the budget from Rs. 2295 Cr to Rs 2732 Cr. in Budget 2024-25. 

 

Here is the Main Heads of the Ministry's expenditure (in Rs crore)

Heads 2022-23 2023-24  2024-25  % Change from 2024-25 Share in Ministry’s Budget
National Health Mission 31279 31551 36000 0.141 0.4
Autonomous Bodies 10073 17251 18014 0.044 0.2
Pradhan Mantri Jan Aarogya Yojana 6186 6800 7300 0.074 0.08
Human Resources for Health and medical education 1975 1520 1275 -0.161 0.01
Central Government Health Scheme 4631 4296 5384 0.253 0.06
PM ABHIM 1542 2300 3757 0.633 0.04
AIDS and STD Control 2143 2421 3049 0.26 0.03
Indian Council of Medical Research 2047 2295 2879 0.19 0.03
Pradhan Mantri Swasthya Suraksha Yojana 7518 1900 2200 0.158 0.03
Others 8338 3449 4148 0.203 0.05
Total 75731 80518 90659 0.13  

 

 

Get stock market courses for free by opening a demat account with stockdaddy, know how to open demat account

 

 

List of Best Pharma Stocks in India to Buy in 2025

As a investor you need to know  how to choose stocks for long term investment in india, but you always know the important ratio in stock market

Company Market Capitalization (in Cr.) Current Share Price (INR) Debt to Equity Ratio ROE (%)
Cipla 94,800 1,174 0.04 12.8
Dr. Reddy Laboratories 90,019 5,397 0.05 21.6
Aurobindo Pharma 50,066 854 0.2 7.47
Lupin 51,514 1,132 0.36 3.33
Torrent Pharma 65,004 1,921 0.67 20

 

1). Cipla: A Pillar of the Pharmaceutical Industry

Cipla - stockdaddy

Cipla, a global pharmaceutical company, has been a stalwart in the industry. Its commitment to quality and affordable healthcare solutions has made it a favorite among investors.

Cipla is the third largest prescription drugs in India. 85% of physicians prescribe at least one Cipla product. Company ranks 1st in Respiratory care in India.

Cipla has portfolio of 1500+ products in 50+ dosage forms and 65 therapeutic categories, company major products are Maxirich, Nicotex, Cofsils, Omnigel, Cipladine, Prolyte Ors.

 
Market Capitalization: 94,800 crore
Current Share Price: Rs. 1,174
Debt to Equity Ratio: 0.04
ROE: 12.8

 

 

2). Dr. Reddy: Leading Innovation in Healthcare

Dr. Reddy - stockdaddy

Dr. Reddy is renowned for its innovation and dedication to improving healthcare worldwide. It's a name that stands for excellence in pharmaceuticals.


Market Capitalization: 90,019 crore
Current Share Price: Rs. 5,397
Debt to Equity Ratio: 0.05
ROE: 21.6

 

 

3). Auropharma: Shaping the Future of Medicine

Auropharma - stockdaddy

Auropharma is a research-driven pharmaceutical company, playing a pivotal role in advancing the healthcare industry. Its commitment to quality is a hallmark of its success.


Market Capitalization: 50,066 crore
Current Share Price: Rs.854
Debt to Equity Ratio: 0.20
ROE: 7.47

 

 

4). Lupin: A Global Pharmaceutical Giant

Lupin - stockdaddy

Lupin, with its global presence, has consistently proven itself as a pharmaceutical giant. It is dedicated to improving the quality of life through its pharmaceutical products.


Market Capitalization: 51,514
Current Share Price: Rs. 1,132
Debt to Equity Ratio: 0.36
ROE: 3.33

 

 

5). Torrent Pharma: A Prescription for Success

Torrent Pharma - stockdaddy

Torrent Pharma has been successful in the pharmaceutical sector, and its dedication to patient well-being is evident in its products and practices.


Market Capitalization: 65,004 crore
Current Share Price: Rs. 1,921
Debt to Equity Ratio: 0.67
ROE: 20

 

 

6). Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals - stockdaddy

Emcure Pharmaceuticals Ltd is an Indian company that was founded in 1981. The company develops, manufactures, and markets a wide range of pharmaceutical products globally.

Today, on 10th July 2025, the company is listed on the stock market.

Emcure is the largest pharmaceutical company in gynaecology and HIV antivirals therapeutic areas, based on domestic sales for MAT FY2024.

The company operates 13 manufacturing plants in India and produces a wide range of dosage forms, including oral solids, liquids, injectables (liposomal and lyophilized), biotherapeutics, and complex APIs such as chiral, iron, and cytotoxic products.

 

 

Why Invest in Pharma Stocks?

Pharmaceutical stocks are often considered a safe haven for investors due to the industry's resilience and consistent demand for healthcare products. These top 5 pharma stocks, including Cipla, Dr. Reddy, Auropharma, Lupin, and Torrent Pharma, offer the potential for long-term growth and stability in your investment portfolio.

 

 

Things to look out for before Investing in Pharma Stocks

 

1). Expanding Access to Healthcare Facilities

India is renowned for its historically low doctor-to-patient ratio, which measures the number of doctors per thousand individuals. Nevertheless, this situation is swiftly improving, thanks to the proliferation of medical colleges.
As the number of doctors, medical colleges, and hospitals continues to rise in India, it becomes increasingly evident that the pharmaceutical sector's potential for growth cannot be underestimated.

 

With technical analysis course learn how to predict the price movement of a specific stock using historical data and volume.

 

2). Surging Incidence of Chronic Diseases

Transforming lifestyles in India, influenced by factors such as rapid urbanization, unhealthy dietary patterns, environmental degradation, sedentary living, and more, have resulted in a notable upswing in chronic health issues.
These factors are poised to propel the growth of the chronic therapeutic sector, which, in turn, promises enhanced profitability for pharmaceutical firms.

 

3). Robust Portfolio of Off-Patent Drugs

As certain blockbuster drugs gradually lose their patent protection, Indian pharmaceutical companies are expected to witness substantial growth in their export market.
These companies currently export their products to more than 200 countries, including both regulated and semi-regulated markets, providing them with a wide spectrum of opportunities for expansion."

 

 

In Conclusion

As you consider your investment options, these top 5 pharmaceutical companies should definitely be on your list. Their strong financials, commitment to innovation, and dedication to shareholder value make them attractive prospects for investors looking for long-term growth and stability.

 

 

FAQ (Frequently Asked Question)

 

Que 1. Are Pharma stocks good for long term investment?

Ans. Although they carry some risk, pharmaceutical stocks can be wise investments. Drug pipelines, patent expirations, and regulatory approvals all affect the industry's performance. Geopolitical factors and trends in healthcare can change the dynamics of the market. Profitability is also impacted by competition and the possibility of generic medications. Investors ought to evaluate individual companies based on their financial stability, R&D pipelines, and product portfolios. It is essential to diversify in order to reduce risk. Although there is room for growth in this industry, it is crucial to stay up to date on new developments and regulatory changes. To navigate the inherent complexities of the pharmaceutical industry, investing in pharma stocks ultimately requires thorough research and a long-term perspective.

 

Que 2. List of pharma stocks below 100 Rs?

Ans. Here is the list of pharma stocks below 100 Rs are:

Company Name Share Price (Rs) Market Cap (Cr)
Alembic Limited 92 2366
Parnax Lab 86.89 99.8
Ind-Swift Lab 97 573
Krebs Biochem. & Industires 79.4 171.19
Alpa Lab 100 211.8
Suven Life Sciencies 79.05 1723.87

 

Que 3. List of pharma stocks below 50 Rs?

Ans. Here is the list of pharma stocks below 50 Rs are:

Company Name Share Price (Rs) Market Cap (Cr)
Morepen Laborataries Ltd 38 1985
Bharat Immunologicals and Biologicals Corporation Ltd 22 97
Nectar Lifescience Ltd 26.45 592
Ambalal Sarabhai Enterprises Ltd 32.64 249.9
Kimai Biosciencies Ltd 34.5 165
Lasa Supergenerics 31.2 160.5
Aarey Drugs and Pharmaceuticals Ltd 48 120.32
Pharmaids Pharmacuticals Ltd 38.9 80.92
Bio Chemical & pharnacuticals Ltd 78.3 48.25

 

Que 4. List of pharma stocks below 10 Rs?

Ans. Here is the list of pharma stocks below 10 Rs are:

Company Name Share Price (Rs) Market Cap (Cr)
Syncom Formulations (India) Ltd 8.6 808.4
Gennex Laboratories Ltd 8.03 144.64
Vivanta Industries Ltd 6.19 59.8
Ajooni Biotech 4.2 41.32
Parabolic Drugs Ltd 5.5 34.04
Earum Pharmacuticals Ltd 1 25.2
Ganga Pharmaceuticals Ltd 9.7 3.29
Bacil Pharma Ltd 7.43 4.61
Kabra Drugs Ltd 3.94 1.65
Welcure Drugs and Pharmacuticals Ltd 3.8 5.2

 

Ques 5. List of small cap pharma stocks in India?

Ans. Here is the list of small cap pharma stocks in India are: 

S.No

Name CMP Rs. P/E Mar Cap
1 Aarti Drugs 514.9 36.6 4733.69
2 Morepen Labs. 84.8 39.45 4646.61
3 Unichem Labs. 652.45   4593.61
4 Supriya Lifesci. 563.55 33.5 4535.62
5 Hikal 366.85 66.82 4523.28
6 Innova Captab 760 40.93 4349.1
7 RPG LifeScience. 2575 46.22 4258.75
8 Jeena Sikho 1602.45 58.66 3983.71
9 Guj. Themis Bio. 357 71.15 3890.09
10 Gufic BioScience 383 44.44 3840.66
11 SMS Pharma. 373.4 56.01 3160.98
12 Indoco Remedies 339.55 46.74 3130.04
13 Dishman Carbogen 176.2   2762.45
14 Solara Active 766.05   2758.19
15 IOL Chemicals 459.45 22.71 2697.22
16 Novartis India 1089.45 29.69 2689.92
17 Themis Medicare 276.2 50.79 2542.13
`18 Amrutanjan Healt 772.6 52.46 2233.65
19 Hester Bios 2388.6 105.23 2031.95
20 Syncom Formul. 21.32 74.11 2004.08
21 Panacea Biotec 322.3   1974.01
22 Sigachi Indust. 54.48 30.68 1816.71
23 Windlas Biotech 863.55 30.29 1804.91
24 Kopran 326.4 26.56 1573.6
25 Beta Drugs Ltd 1635 43.15 1571.84
26 Remus Pharma. 2580 73.97 1520.14
27 Bliss GVS Pharma 132 13.06 1387.96
28 Lincoln Pharma. 674.85 13.8 1351.69
29 NGL Fine Chem 1983.4 31.79 1225.73
30 Jagsonpal Pharma 434.65 50.5 1151.17
31 Bharat Parenter. 1630   1063.5

 

Ques 6. List of penny pharma stocks in India?

Ans. Here is the list of penny pharma stocks in India?

S.No. Name CMP Rs. Mar Cap
1 Shree Ganesh Bio 1.01 40.25
2 Zenith Health 5.41 29.07
3 Cian Healthcare 5.16 12.9
4 Welcure Drugs 7.69 10.39
5 MPS Pharmaa 3.95 7.55
6 Kobo Biotech 2.95 7.04
7 Raymed Labs 2.62 1.12

 

Ques 7. Which Indian pharma stocks near 52-week lows?

Ans. Here is the list of pharma stocks near 52-week lows:

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr.  52w Low Rs.
1 SPARC 209.45   6797.12 196.1
2 Quest 111 18.05 181.9 102
3 Syschem (India) 43.48 140.94 173.3 39.45
4 Medicamen 62.4 30.42 73.01 61
5 ANG Lifesciences 50.86   66.4 44.49
6 Sandu Pharma. 58.56 37.22 56.58 55.15
7 Dipna Pharmachem 7.89 17.42 18.99 7
8 Cian Healthcare 5.16 51.6 12.9 5.16

 

Ques 8. List of pharma stocks with low P/E?

Ans. It totally depends on sectors P/E and pharma sector P/E is 38, so if  you want to choose the stocks on basis of P/E ratio, then you should look the stocks below which are below 38.

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr.  52w Low Rs. 52w High Rs.
1 Cipla 1656.95 30.21 133914.38 1132 1684.95
2 Dr Reddy's Labs 6714.2 20.14 112080.22 5205.55 7107.45
3 Zydus Lifesci. 1068.85 25.8 107526.44 567.75 1324.3
4 Aurobindo Pharma 1458.45 23.87 85441.36 834.65 1592.55
5 Alkem Lab 6179.95 34.48 73886.37 3440.05 6440
6 Biocon 356.95 27.45 42884.35 217.5 395.8
7 Caplin Point Lab 2010 31.98 15262.92 950 2158.8
8 Granules India 595.7 29.32 14430.43 318.95 724.55
9 Glenmark Life 1130.55 30.97 13843.25 608.55 1335.1
10 FDC 530.4 27.49 8638.66 343.3 659

 

stock market courses with stockdaddy
stock market courses for beginners with stockdaddy
stock market learning course with stockdaddy
trading stock market courses with stockdaddy
share market certificate course with stockdaddy
share market courses with stockdaddy